ClinConnect ClinConnect Logo
Search / Trial NCT06693700

A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home

Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · Nov 14, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Smoking Smoking Cessation Smoking Reduction Smoking Habit Smoking Behaviors Smoking, Tobacco Smoking, Cigarette Smoking (Tobacco) Addiction Tobacco Use Tobacco Smoking Air Quality Indoor Air Quality Monitoring Devices 24 260 Memorial Sloan Kettering Cancer Center

ClinConnect Summary

This clinical trial is studying how an indoor air quality monitor can help create a smoke-free home for cancer patients who are part of the Tobacco Treatment Program at MSK. The goal is to see if having this device in their home can encourage patients and their families to reduce or quit smoking. The study is currently recruiting participants who are 18 years or older, smoke tobacco products, and live with at least one household member who also smokes. Participants need to be able to speak English and have Wi-Fi at home.

If you or a loved one qualify for this trial, you can expect to use the air quality monitor in your home and receive support as part of the program. This could be a great opportunity for those looking to make their environment healthier and reduce tobacco use. There are no specific exclusion criteria, so if you meet the inclusion requirements, you may be eligible to participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult (aged \>18 years) MSK patients as per the EHR
  • Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
  • Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
  • Must be English-speaking in the EHR
  • Must be reachable by phone as per self-report
  • Must have Wi-Fi available at home as per self-report
  • Exclusion Criteria:
  • Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report

About Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to cancer treatment, research, and education. As a leading clinical trial sponsor, MSKCC focuses on advancing innovative cancer therapies through rigorous scientific investigation and collaboration. The center's multidisciplinary team of experts employs cutting-edge methodologies to design and conduct trials that aim to improve patient outcomes and enhance understanding of cancer biology. With a commitment to translating research findings into clinical practice, MSKCC plays a pivotal role in shaping the future of oncology care and ensuring that patients have access to the latest therapeutic advancements.

Locations

New York, New York, United States

Montvale, New Jersey, United States

Uniondale, New York, United States

Harrison, New York, United States

Basking Ridge, New Jersey, United States

Middletown, New Jersey, United States

Commack, New York, United States

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Jamie Ostroff, PhD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported